MétaCan
Menu
Back to cohort
Record W4288698300 · doi:10.2967/jnumed.121.263768

<sup>68</sup>Ga-DOTATATE Prepared from Cyclotron-Produced<sup>68</sup>Ga: An Integrated Solution from Cyclotron Vault to Safety Assessment and Diagnostic Efficacy in Neuroendocrine Cancer Patients

2022· article· en· W4288698300 on OpenAlexafffund
Sébastien Tremblay, Jean-François Beaudoin, Ophélie Bélissant Benesty, Samia Aı̈t-Mohand, Véronique Dumulon‐Perreault, Étienne Rousseau, Éric Turcotte, Brigitte Guérin

Bibliographic record

VenueJournal of Nuclear Medicine · 2022
Typearticle
Languageen
FieldMedicine
TopicNeuroendocrine Tumor Research Advances
Canadian institutionsUniversité de Sherbrooke
FundersFonds de Recherche du Québec - SantéUniversité de SherbrookeMerck CanadaCancer Research Society
KeywordsCyclotronBiodistributionNuclear medicineNeuroendocrine tumorsChemistryRadiochemistryMedicinePhysicsNuclear physicsElectronInternal medicine

Abstract

fetched live from OpenAlex

Cyclotron production of gallium-68 (68Ga) is a promising approach to supply 68Ga radiopharmaceuticals. To validate this capability, an integrated solution for a robust synthesis of 68Ga-DOTATATE prepared from cyclotron produced 68Ga (further on referred to as cyclotron produced 68Ga-DOTATATE) was achieved. A retrospective comparison analysis was performed in patients who underwent PET/CT imaging after injection of DOTATATE labeled with 68Ga produced by cyclotron or eluted from a generator to demonstrate the clinical safety and diagnostic efficacy of the radiopharmaceutical for a routine standard-of-care diagnostic tool in clinic. Methods: An enriched zinc-68 pressed target was irradiated by cyclotron with a proton beam set at 12.7 MeV for 100 min. The fully automated process utilizes an in-vault dissolution system where a liquid distribution system transfers the dissolved target to a dedicated hotcell for the purification of 68GaCl3 and radiolabeling of DOTATATE using a cassette-based automated module. Quality control tests were performed on the resulting tracer solution. The internal radiation dose for 68Ga-DOTATATE was calculated based on extrapolation from rat biodistribution experiments. A retrospective comparison analysis was performed in patients who underwent PET/CT imaging after injection of DOTATATE labeled with 68Ga produced by cyclotron or eluted from a generator. Results: The synthesis of 68Ga-DOTATATE (20.7 ± 1.3 GBq) with high apparent molar activity (518 ± 32 GBq/µmole at end of synthesis (EOS)) was completed in 65 min and the radiopharmaceutical met the requirements specified in the European Pharmacopeia monograph on Gallium (68Ga) chloride (accelerator produced) solution for radiolabeling. 68Ga-DOTATATE was stable for at least 5 h after formulation. The dosimetry calculated with OLINDA for 68Ga-DOTATATE from cyclotron produced 68Ga and generator eluted 68Ga was roughly equivalent. The SUVmean or SUVmax of tumoral lesions with cyclotron produced 68Ga-DOTATATE was equivalent to that with generator-eluted 68Ga. Among physiological uptakes, a significant difference was found in kidneys, spleen and stomach wall, with lower values in cyclotron produced 68Ga-DOTATATE in all cases. Conclusion: Integrated cyclotron production achieves reliable high yields of clinical-grade 68Ga-DOTATATE. The clinical safety, and imaging efficacy of cyclotron produced 68Ga-DOTATATE in humans provide supporting evidence for its use in routine clinical practice.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.004
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.382
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.004
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.001
Open science0.0010.001
Research integrity0.0000.002
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.335
Teacher spread0.316 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations9
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Nuclear MedicineSame topicNeuroendocrine Tumor Research AdvancesFrench-language works237,207